![Tracey O’Brien: eviQ is one of the best examples of clinician-led, evidence-based tools out there](https://oncodaily.com/pub/uploads/2023/09/1687830824190-e1699122953823.jpeg)
Tracey O’Brien: eviQ is one of the best examples of clinician-led, evidence-based tools out there
Quoting Tracey O’Brien on LinkedIn:
“In my humble (possibly biased) opinion, eviQ is one of the best examples of clinician-led, evidence-based, consensus-driven tools out there. Click on the link to learn more from cancer leaders across the country.
EviQ supports health professionals in the delivery of cancer care and drives better outcomes for patients. It’s proudly delivered by Cancer Institute NSW but is a national resource drawing on cancer experts Australia-wide.
It is an exemplar of what cross-boundary clinician collaboration can achieve and is a stalwart in Australian cancer care. We invite you to join a reference committee.”
Source: Tracey O’Brien/LinkedIn
Dr. Tracey O’Brien is the NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, Australia. Before her current role, Tracey was Director of the Kids Cancer Centre, Sydney Children’s Hospital, and Director of the Transplant & Cellular Therapy Program.
Tracey has held numerous high-profile national and international leadership positions, including Advisory Chair, Cancer Australia; V/Chair (Africa, Asia and Australasia) International Centre for Bone Marrow Transplant Research and V/President of the Australian and New Zealand Children’s Oncology Group.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023